Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Harding

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Current Medical Research and Opinion|June 19, 2015
Practical experience with ticagrelor: an Australian and New Zealand perspectiveScott A Harding, William J Van Gaal, Ryan Schrale, et al.
Scientific Reports|June 17, 2021
A combined biomarker approach for characterising extracellular matrix profiles in acute myocardial infarctionMorgane M Brunton-O'Sullivan, Ana S Holley, Kathryn E Hally, et al.
Thrombosis and Haemostasis|August 28, 2007
Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerationsScott A Harding, Jehangir N Din, Jaydeep Sarma, et al.
Journal of Vascular Surgery|September 7, 2010
Perioperative platelet and monocyte activation in patients with critical limb ischemiaAnne Burdess, Alastair F Nimmo, Neil Campbell, et al.
Heart (British Cardiac Society)|November 28, 2012
Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokersJehangir N Din, Rachel M Archer, Scott A Harding, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2003
Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiographyBriain D MacNeill, Scott A Harding, Hasan Bazari, et al.
Thrombosis Research|August 2, 2005
Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarctionNicholas L M Cruden, Catriona Graham, Scott A Harding, et al.
Biomarkers in Medicine|February 2, 2022
Examining variation and temporal dynamics of extracellular matrix biomarkers following acute myocardial infarctionMorgane M Brunton-O'Sullivan, Ana S Holley, Georgina K Bird, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 15, 2011
An unmet need for implantable cardioverter-defibrillators in New ZealandSonya N Burgess, Scott A Harding, Iain C Melton, et al.
Heart, Lung & Circulation|May 19, 2012
Geographic, ethnic and socioeconomic factors influencing access to implantable cardioverter defibrillators (ICDs) in New ZealandDavid Wilson, Scott A Harding, Iain Melton, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Current Medical Research and Opinion|June 19, 2015
Practical experience with ticagrelor: an Australian and New Zealand perspectiveScott A Harding, William J Van Gaal, Ryan Schrale, et al.
Scientific Reports|June 17, 2021
A combined biomarker approach for characterising extracellular matrix profiles in acute myocardial infarctionMorgane M Brunton-O'Sullivan, Ana S Holley, Kathryn E Hally, et al.
Thrombosis and Haemostasis|August 28, 2007
Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerationsScott A Harding, Jehangir N Din, Jaydeep Sarma, et al.
Journal of Vascular Surgery|September 7, 2010
Perioperative platelet and monocyte activation in patients with critical limb ischemiaAnne Burdess, Alastair F Nimmo, Neil Campbell, et al.
Heart (British Cardiac Society)|November 28, 2012
Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokersJehangir N Din, Rachel M Archer, Scott A Harding, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 19, 2003
Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiographyBriain D MacNeill, Scott A Harding, Hasan Bazari, et al.
Thrombosis Research|August 2, 2005
Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarctionNicholas L M Cruden, Catriona Graham, Scott A Harding, et al.
Biomarkers in Medicine|February 2, 2022
Examining variation and temporal dynamics of extracellular matrix biomarkers following acute myocardial infarctionMorgane M Brunton-O'Sullivan, Ana S Holley, Georgina K Bird, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 15, 2011
An unmet need for implantable cardioverter-defibrillators in New ZealandSonya N Burgess, Scott A Harding, Iain C Melton, et al.
Heart, Lung & Circulation|May 19, 2012
Geographic, ethnic and socioeconomic factors influencing access to implantable cardioverter defibrillators (ICDs) in New ZealandDavid Wilson, Scott A Harding, Iain Melton, et al.
Pageof 13